CHC
CRSP icon

City Holding Co’s CRISPR Therapeutics CRSP Stock Holding History

City Holding Co’s Portfolio CRSP Stock Details CRSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-20
Closed -$939 – 470
2024
Q3 		$939 Sell
20
-55
-73% -$2.79K ﹤0.01% 449
2024
Q2 		$4.05K Sell
75
-10
-12% -$578 ﹤0.01% 427
2024
Q1 		$5.79K Sell
85
-29
-25% -$2.08K ﹤0.01% 431
2023
Q4 		$7.14K Sell
114
-60
-34% -$3.32K ﹤0.01% 429
2023
Q3 		$7.89K Sell
174
-1,570
-90% -$81.1K ﹤0.01% 426
2023
Q2 		$97.9K Sell
1,744
-500
-22% -$28.4K 0.02% 274
2023
Q1 		$101K Sell
2,244
-670
-23% -$32.5K 0.02% 259
2022
Q4 		$118K Sell
2,914
-465
-14% -$24.7K 0.02% 248
2022
Q3 		$221K Sell
3,379
-360
-10% -$26.1K 0.04% 214
2022
Q2 		$227K Sell
3,739
-3,535
-49% -$208K 0.04% 207
2022
Q1 		$457K Sell
7,274
-190
-3% -$11.9K 0.07% 177
2021
Q4 		$458K Buy
7,464
+377
+5% +$32.9K 0.08% 173
2021
Q3 		$793K Buy
7,087
+2,873
+68% +$361K 0.14% 140
2021
Q2 		$682K Buy
4,214
+1,167
+38% +$142K 0.12% 140
2021
Q1 		$371K Buy
+3,047
New +$460K 0.07% 164

Other funds holding CRSP

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

City Holding Co's CRSP Position: Q4 2024 in Review

City Holding Co sold out of CRISPR Therapeutics (CRSP) in Q4 2024, closing a stake of 20 shares — an estimated $939 sold.

City Holding Co first reported a position in CRSP in Q1 2021 and held it in 15 quarters. The position peaked at $793K in Q3 2021. 404 funds tracked by Wall St. Rank hold CRSP as of Q4 2024.

  • City Holding Co reported no remaining CRISPR Therapeutics position as of Q4 2024 after selling out during the quarter.
  • City Holding Co sold 20 CRISPR Therapeutics shares in Q4 2024, an estimated $939.
  • City Holding Co first reported a position in CRISPR Therapeutics in Q1 2021 and held it in 15 quarters.
  • City Holding Co's CRISPR Therapeutics position peaked at $793K in Q3 2021.
  • 404 funds tracked by Wall St. Rank held CRISPR Therapeutics as of Q4 2024.

Based on City Holding Co's 13F filing for Q4 2024, filed 16 Jan 2025.